To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19

meplazumab - Jiangsu Pacific Meinuoke Biopharmaceutical, Air Force Medical University

http://clinicaltrials.gov/ct2/show/NCT05813587

Feb 23, 2024